EGFR Positive UK
Home News Contact
Donate
Our Mission Our Early Diagnosis Campaigns Real Life Stories Who We Are 5 Years of EGFR+ UK! Inclusion and Diversity Our Policies Annual Report 2024/25
What is EGFR? Treatment Options Glossary
EGFR+ UK Conferences 2025/6 EGFR Good Practice Guide Crisis support Videos Mental Wellbeing Support Clinical Trials Travelling with Lung Cancer Other Resources
Donating Fundraising
Home About Us Our Mission Our Early Diagnosis Campaigns Real Life Stories Who We Are 5 Years of EGFR+ UK! Inclusion and Diversity Our Policies Annual Report 2024/25 About EGFR What is EGFR? Treatment Options Glossary Patient Support EGFR+ UK Conferences 2025/6 EGFR Good Practice Guide Crisis support Videos Mental Wellbeing Support Clinical Trials Travelling with Lung Cancer Other Resources NewsContact Get Involved Donating Fundraising
EGFR Positive UK
Offering hope & learning for those with EGFR+
Donate

UKLCC Early Diagnosis Matters Report

 
 
CLICK TO DOWNLOAD

CLICK TO DOWNLOAD

 
EGFR PositiveFebruary 4, 2020
Facebook0 Twitter LinkedIn0 Reddit Tumblr Pinterest0 0 Likes
Previous

Adjuvant Osimertinib in Early-Stage EGFR-Positive NSCLC

Guest UserJune 10, 2020
Next

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

EGFR PositiveNovember 25, 2019

The latest news

News
EGFR+ UK One-Day Conferences
Aug 21, 2025
EGFR+ UK One-Day Conferences
Aug 21, 2025
Read More →
Aug 21, 2025
2025 Members' Survey now open!
Aug 2, 2025
2025 Members' Survey now open!
Aug 2, 2025
Read More →
Aug 2, 2025
EGFR+ UK at BTOG!
May 10, 2025
EGFR+ UK at BTOG!
May 10, 2025
Read More →
May 10, 2025
Run the London Marathon for EGFR+ UK - Appy Now!
May 1, 2025
Run the London Marathon for EGFR+ UK - Appy Now!
May 1, 2025
Read More →
May 1, 2025
Thank You to Natasha as She Changes Role
Mar 31, 2025
Thank You to Natasha as She Changes Role
Mar 31, 2025
Read More →
Mar 31, 2025
A New First-Line Option for EGFR+ Lung Cancer
Mar 27, 2025
A New First-Line Option for EGFR+ Lung Cancer
Mar 27, 2025
Read More →
Mar 27, 2025

EGFR+ UK are proud members of Lung Cancer Europe

 
 

NEW! Follow us on Bluesky 🦋

 
 
View fullsize Thanks to Kate Wells from the @ruthstraussfoundation for joining us for our recent Meet the Expert session on talking to children about a lung cancer diagnosis. 💜 Kate shared compassionate, practical advice on how to approach these conversations wi
View fullsize 💚 Thank you to everyone who joined us in Bristol for our second L EGFR+ UK one-day conference. We’ve had great feedback from the day and we’re delighted to confirm we’ll be back in Bristol on 14 October 2026. Next up: 📍 Edinburgh
View fullsize News from ESMO 2025: 
Zipalertinib is being studied for people with advanced EGFR-positive lung cancer who have active brain metastases - specifically EGFR exon 20 insertions or other uncommon EGFR mutations.   Early results from the REZILIENT2
View fullsize

Medical Disclaimer

The contents of this website are for informational purposes. The content is NOT a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified professional with any question you have regarding a medical condition. EGFR Positive UK does not endorse any companies, products or opinions that may be mentioned on this website.

 

© 2025 EGFR POSITIVE UK - Charity nº 1189722


PRIVACY POLICY

COOKIE POLICY